- Home
- XNCR vs LPTH Comparison
XNCR vs LPTH Comparison
Compare XNCR & LPTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XNCR | LPTH |
|---|---|---|
| Founded | 1997 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2013 | 2011 |
Fundamental Metrics
Financial Performance| Metric | XNCR | LPTH |
|---|---|---|
| Price | $16.87 | $10.48 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | ★ $22.33 | $13.33 |
| AVG Volume (30 Days) | 958.3K | ★ 3.1M |
| Earning Date | 05-08-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 65.36 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $125,576,000.00 | $37,202,630.00 |
| Revenue This Year | N/A | $83.04 |
| Revenue Next Year | $4.80 | $24.83 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 13.65 | ★ 17.26 |
| 52 Week Low | $6.92 | $2.91 |
| 52 Week High | $18.69 | $18.94 |
Technical Indicators
Market Signals| Indicator | XNCR | LPTH |
|---|---|---|
| Relative Strength Index (RSI) | 71.16 | 35.56 |
| Support Level | $11.06 | $10.06 |
| Resistance Level | $18.69 | $10.59 |
| Average True Range (ATR) | 1.02 | 1.27 |
| MACD | -0.00 | -0.35 |
| Stochastic Oscillator | 97.16 | 9.03 |
Price Performance
Historical ComparisonAbout XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.
About LPTH LightPath Technologies Inc.
LightPath Technologies Inc manufactures, distributes, and integrates proprietary optical components and assemblies. It develops optical solutions for traditional optics and communications markets. The company's products include precision molded optics and infrared products, serving markets such as distribution, laser, industrial, instrumentation, telecommunications, and defense. Its products are categorized as infrared components, visible components, assemblies and modules, and engineering services. G5 Infrared's revenue mainly comes from infrared components and assemblies.